Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.5300
+0.0400 (8.16%)
Oct 9, 2026, 3:46 PM EST
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 37.09 million as of October 9, 2026. It is the 35,209th most valuable company in the world and the 1,074th biggest in Canada. Its market cap has decreased by 4.60% in one year.
Market Cap
37.09M
Enterprise Value
29.81M
Revenue
n/a
Global Rank
Country Rank
#1,074 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 37.09M, an increase of 165.78%. That is a compound annual growth rate of 24.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 37.09M | 10.08% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sernova Biotherapeutics | 45.32M |
| Sharp Therapeutics | 43.26M |
| Microbix Biosystems | 43.15M |
| MedMira | 42.10M |
| Medicenna Therapeutics | 41.54M |
| Sona Nanotech | 40.52M |
| Telescope Innovations | 33.14M |
| Defence Therapeutics | 30.32M |